Skip to content
naulon
Not checkedNot checked for notices yet.

Allicin and Glycyrrhizic Acid Display Antiviral Activity Against Latent and Lytic Kaposi Sarcoma-associated Herpesvirus

Yirui Xie, Ying Chen, Yongzheng Guo and 3 more

Infectious Microbes & Diseases · 2020

doi:10.1097/im9.0000000000000016 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) triggers the development of Kaposi sarcoma, a skin malignancy that is one of the most widespread defining symptoms in acquired immunodeficiency syndrome patients. KSHV manifests in two distinct cycles, a chronic latent cycle and an acute lytic cycle. Current clinical anti-herpesvirus therapeutic agents are predominantly composed of nucleoside analogues that target viral replication in the lytic cycle only, while KSHV latent genes are at the basis tumorigenesis. Currently, there are no effective therapies targeting latent KSHV infections. Therefore, the aim of this study was to identify putative therapeutic compounds with inhibitory activity against latent KSHV. The KSHV-infected primary effusion lymphoma cell line BC-3 was used to study antiviral activity of glycyrrhizic acid (GA), Allicin, and epigallocatechin-3-gallate (EGCG) against latent and lytic KSHV. Activity of GA, Allicin, EGCG, and the established anti-lytic cycle control compound ganciclovir was quantified by real-time polymerase chain reaction of nuclear and virion KSHV DNA yields after treatment compared with the untreated control. GA and Allicin showed antiviral activity against both latent and lytic KSHV, while EGCG displayed activity against lytic KSHV only. Therefore, GA and Allicin are interesting compounds for further development of anti-KSHV therapy against latent cycle infections.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.